Wade T. Iams

3.9k total citations · 1 hit paper
95 papers, 2.2k citations indexed

About

Wade T. Iams is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wade T. Iams has authored 95 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 21 papers in Cancer Research. Recurrent topics in Wade T. Iams's work include Lung Cancer Treatments and Mutations (37 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Research Studies (26 papers). Wade T. Iams is often cited by papers focused on Lung Cancer Treatments and Mutations (37 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Research Studies (26 papers). Wade T. Iams collaborates with scholars based in United States, Spain and United Kingdom. Wade T. Iams's co-authors include Christine M. Lovly, Young Kwang Chae, Leora Horn, Marcelo Cruz, Jason Porter, Francis J. Giles, Sunandana Chandra, Ayush Arya, Jaehyuk Choi and Jonathan F. Anker and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Wade T. Iams

90 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

2018 321 citations Young Kwang Chae, Wade T. Iams et al. profile →

Peers

Countries citing papers authored by Wade T. Iams

Since Specialization

Citations

This map shows the geographic impact of Wade T. Iams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wade T. Iams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wade T. Iams more than expected).

Fields of papers citing papers by Wade T. Iams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wade T. Iams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wade T. Iams. The network helps show where Wade T. Iams may publish in the future.

Co-authorship network of co-authors of Wade T. Iams

This figure shows the co-authorship network connecting the top 25 collaborators of Wade T. Iams. A scholar is included among the top collaborators of Wade T. Iams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wade T. Iams. Wade T. Iams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast 2025 ·Oncology and Therapy ·Balázs Halmos, (unknown), (unknown), Wade T. Iams, Xiuning Le, (unknown), (unknown), Luis E. Raez, Jonathan W. Riess, Joshua K. Sabari, (unknown), (unknown), Yichuan Xia, (unknown), Denise D’Andrea, (unknown), Andrew L. Johnson, Melissa L. Johnson	0
2	Eftilagimod Alpha Plus Pembrolizumab in First-Line Metastatic Non–Small Cell Lung Cancer: Results From a PD-L1–Unselected Population in the TACTI-002 Study 2025 ·Margarita Majem, Enric Carcereny, Bernard Doger, Timothy Clay, Igor Bondarenko, Julio A. Peguero, Manuel Cobo, Martin Förster, Ewa Kalinka‐Warzocha, (unknown), Laia Vilà, Wade T. Iams, Matthew Krebs, Begoña Campos, Christian Mueller, (unknown), Frédéric Triebel	0
3	Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials 2025 ·Clinical Cancer Research ·David E. Gerber, (unknown), Tanushree Prasad, (unknown), Song Zhang, Thomas E. Stinchcombe, Liza C. Villaruz, Joshua Bauml, Wade T. Iams, Tejas Patil, Stephen V. Liu, Leora Horn, (unknown), D. Ross Camidge	1
4	Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report 2025 ·Oncotarget ·(unknown), Wade T. Iams	0
5	Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration 2024 ·Molecular Carcinogenesis ·Alice N. Weaver, Wade T. Iams, Jong Chul Park, Monica Mita, Udo Holtick, Michael S. Gordon, Kerry J. Rodabaugh, Neesha C. Dhani, Prakash Neupane, Matthew H. Taylor, (unknown), (unknown), Nathan R. Miselis, Scott Loughhead, Marshelle Warren, Howard Bernstein, Jens Peter Klußmann, Joaquina Baranda, Antonio Jimeno	2
6	Lurbinectedin versus platinum rechallenge in relapsed extensive stage small cell lung cancer: A retrospective cohort study. 2024 ·Journal of Clinical Oncology ·(unknown), M Lu, (unknown), Jenny Wu, (unknown), Wade T. Iams	1
7	SWOG S2302, PRAGMATICA-LUNG: A prospective randomized study of ramucirumab plus pembrolizumab (PR) versus standard of care (SOC) for participants previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer. 2024 ·Journal of Clinical Oncology ·Karen L. Reckamp, Mary W. Redman, Konstantin H. Dragnev, Wade T. Iams, Brian S. Henick, Jieling Miao, Michael LeBlanc, Daniel R. Carrizosa, Roy S. Herbst, Charles D. Blanke, Jhanelle E. Gray	5
8	Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors 2024 ·ESMO Open ·Bradford A. Perez, Raid Aljumaily, Thomas U. Marron, Michael Shafique, Howard A. Burris, Wade T. Iams, Steven J. Chmura, Jason J. Luke, William J. Edenfield, Davendra Sohal, Xiaoyun Liao, Carsten Boesler, (unknown), (unknown), (unknown), (unknown), (unknown), Scott Antonia	10
9	Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast 2023 ·Advances in Therapy ·Wade T. Iams, Kartik Konduri	1
10	Peripheral T-cell receptor repertoire dynamics in small cell lung cancer 2023 ·Translational Lung Cancer Research ·(unknown), Margaret L. Axelrod, Justin M. Balko, Armand Bankhead, Tristan Shaffer, Lee Yong Lim, Jiannan Guo, Jennifer Hernandez, Mark Li, Wade T. Iams	3
11	A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer 2023 ·Clinical Lung Cancer ·Wade T. Iams, (unknown), Sharon Phillips, Adrian G. Sacher, Christine M. Bestvina, Vamsidhar Velcheti, Xiao Wang, Melina E. Marmarelis, Nan Sethakorn, Ticiana Leal, Paul Sackstein, Chul Kim, (unknown), Kathan Mehta, (unknown), Jorge J. Nieva, Tejas Patil, D. Ross Camidge	2
12	Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules 2023 ·CHEST Journal ·(unknown), Michael N. Kammer, (unknown), Samira Shojaee, Brent E. Heideman, Tobias Peikert, (unknown), Wade T. Iams, Boting Ning, Marc E. Lenburg, Christopher Mallow, Lonny Yarmus, Kwun M. Fong, Stephen A. Deppen, Eric L. Grogan, Fabien Maldonado	15
13	Carcinoid tumors outside the abdomen 2022 ·Cancer Medicine ·(unknown), Wade T. Iams	1
14	Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer 2021 ·Cancers ·(unknown), Wade T. Iams	18
15	Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors 2020 ·Molecular Cancer Therapeutics ·Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex Robertson, (unknown), Rohith Srivas, Timothy J. Wilson, Nicole Lambert, Peter George, Becky J. Wong, (unknown), (unknown), (unknown), (unknown), (unknown), Young Kwang Chae	17
16	Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations 2019 ·Clinical Cancer Research ·Thereasa A. Rich, Karen L. Reckamp, Young Kwang Chae, Robert C. Doebele, Wade T. Iams, Michael S. Oh, Victoria M. Raymond, Richard B. Lanman, Jonathan W. Riess, Thomas E. Stinchcombe, Vivek Subbiah, David R. Trevarthen, Stephen R. Fairclough, Jennifer Yen, Oliver Gautschi	68
17	P1.01-49 Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC 2019 ·Journal of Thoracic Oncology ·Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex Robertson, Amit B. Shah, Rohith Srivas, Nicole Lambert, Timothy J. Wilson, (unknown), (unknown), (unknown), Nisha Mohindra, Victoria Villaflor, (unknown)	1
18	Radiation Oncology Education for Medical Oncology Fellowship Trainees: A Pilot Needs Assessment 2018 ·International Journal of Radiation OncologyBiologyPhysics ·N Paudel, Barbara Pro, (unknown), Wade T. Iams, Daniel W. Golden, Tim J. Kruser	1
19	Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies 2015 ·Cancer Immunology Research ·Douglas B. Johnson, Christine M. Lovly, Marisa Flavin, Katherine S. Panageas, Gregory D. Ayers, Zhiguo Zhao, Wade T. Iams, (unknown), (unknown), Charles R. Terry, Elizabeth Berry, A. John Iafrate, Ryan J. Sullivan, Richard D. Carvajal, Jeffrey A. Sosman	132
20	Full-Thickness Skin Graft Overlying a Separately Harvested Auricular Cartilage Graft for Nasal Alar Reconstruction 2013 ·JAMA Facial Plastic Surgery ·David A. Zopf, Wade T. Iams, Jennifer C. Kim, Shan R. Baker, Jeffrey S. Moyer	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact